2 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 2 | Terminated 2 |
Follow Metastatic Solid Tumors: new trials by email Literature Review of Metastatic Solid Tumors trials Research Report on Metastatic Solid Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors INCB177054, Retifanlimab - Solid Tumors, Advanced Solid Tumors | Phase 1 / Phase 2 | Terminated | Incyte Corporation | 9 | 2025-06-30 | 2026-09-02 |
| This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors. OBI-888, Globo H IHC Assay - Metastatic Solid Tumors, Locally Advanced Solid Tumors | Phase 1 / Phase 2 | Terminated | OBI Pharma, Inc | 54 | 2018-05-07 | 2024-02-22 |
Incyte Corporation (1) · OBI Pharma, Inc (1)
United States (2) · Taiwan (1)